The Short Answer
Get baseline labs (CBC, ALT, creatinine, hs-CRP, ESR, CK) before starting any DMARD, then repeat every 8–12 weeks while on therapy. Safety thresholds: WBC < 3.0 K/µL (hold methotrexate), ALT > 3× upper limit of normal (reduce dose), creatinine > 1.5 mg/dL (adjust DMARD). Remission targets: hs-CRP < 1.0 mg/L and ESR < 15 mm/hr [2][3].
Baseline labs establish your starting point and rule out organ damage before DMARDs. Complete blood count (CBC) checks white blood cells, red blood cells, and platelets. Liver function tests (ALT, AST) and creatinine assess kidney and liver health. Inflammatory markers (hs-CRP, ESR) and creatine kinase (CK) measure muscle inflammation. These six tests cost $150–$300 and guide your DMARD choice and starting dose [2][3].
Every 8–12 weeks on DMARD therapy, repeat CBC, ALT, creatinine, hs-CRP, ESR, and CK. Methotrexate and azathioprine suppress bone marrow and liver function, so WBC < 3.0 K/µL or ALT > 3× upper limit of normal means you hold the drug and recheck in 1 week. Creatinine > 1.5 mg/dL signals kidney stress and requires dose reduction or switch to a safer agent [2][3].
Remission labs show your DMARD is working. hs-CRP < 1.0 mg/L and ESR < 15 mm/hr mean inflammation is controlled. CK < 150 IU/L shows muscle is healing. Once you hit remission for 6 months, you can space labs to every 3 months and consider slow DMARD tapering under your rheumatologist's guidance. Skipping labs increases flare risk by 40% and organ damage by 60% [1][3].